AGP Executive Report
Last update: 12 hours agoBiotech Push: Agenus published Phase 1b results for botensilimab plus balstilimab in treatment-refractory liver cancer, reporting a 17% objective response rate and a 50% 18-week clinical benefit rate. Xenotransplant Milestone: United Therapeutics said the FDA cleared it to proceed with its pig-derived UHeart xenotransplant trial, starting with up to two patients and aiming for broader expansion after early safety/efficacy review. Local Safety & Health: Leapfrog released spring hospital safety grades, with MountainView Regional Medical Center earning an “A,” while local police reports also flagged a serious construction-zone crash lawsuit and a separate gunshot incident near a hospital in Clinton. Sports & Culture: The FA Cup final at Wembley stayed goalless at halftime as Chelsea and Man City battled, and Philly’s return to London for an Eagles game is already stirring resident gripes over FIFA parking permits. Business Watch: Starbucks announced 300 corporate layoffs and office closures as part of its turnaround.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
